Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer

Authors
Dowsett, M
Sestak, I
Buus, R
Lopez-Knowles, E
Mallon, E
Howell, Anthony
Forbes, J
Buzdar, A
Cuzick, J
Affiliation
Royal Marsden Hospital and Breakthrough Breast Cancer Centre, Institute of Cancer Research, London, United Kingdom
Issue Date
2015-06-15

Metadata
Show full item record
Abstract
To identify the individual genes or gene modules that lead to the OncoptypeDx 21-gene recurrence score's reduced performance after 5 years and thereby identify indices of residual risk that may guide selection of patients for extended adjuvant therapy.
Citation
Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer. 2015, 21 (12):2763-70 Clin Cancer Res
Journal
Clinical Cancer Research
URI
http://hdl.handle.net/10541/560787
DOI
10.1158/1078-0432.CCR-14-2842
PubMed ID
26078431
Type
Article
Language
en
ISSN
1078-0432
Collections